BURTON E. GROSSMAN was a highly respected international businessman and a longtime member of the Wilmer Advisory Council, on which his wife, MIRIAM GROSSMAN, also served until 2001. Dr. Grossman, who died in 1999, was a Texas native and a naturalized Mexican citizen who served as chairman and CEO of Grupo Continental, a holding company he established which owns and operates 46 corporations dealing with soft drinks, sugar refining, mineral water, cooling systems, and plastics.
Dr. Grossman, who had been treated for a rare eye condition at the Wilmer Eye Institute and whose father had lost his sight from glaucoma, was a strong advocate for the integration of efforts to understand the progression of specific ophthalmologic diseases and the incorporation of the principles of public health in the prevention of blindness.
Held by Oliver D. Schein
OLIVER D. SCHEIN, MD, MPH, is the Burton E. Grossman Professor of Ophthalmology for the International Prevention of Blindness at the Wilmer Eye Institute and carries a joint appointment in the Department of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health. Dr. Schein’s clinical expertise is in medical and surgical conditions of the anterior segment of the eye, including cataract and complications of cataract surgery, corneal scarring, and corneal surgery. He is a past author of the American Academy of Ophthalmology’s “Preferred Practice Pattern” on Cataract. His research activities are directed toward the epidemiology of major ocular diseases, ophthalmic technology assessment, and outcomes research in ophthalmology.
Dr. Schein received his MD and MPH degrees from Johns Hopkins University and completed his ophthalmology residency and cornea and external eye disease fellowship at Harvard University’s Massachusetts Eye and Ear Infirmary. He joined the Wilmer faculty in 1988.